Published in TB and Outbreaks Week, January 15th, 2002
Signed December 17, 2001, the alliance lets MMI integrate a 12-month, national data feed from Focus's The Surveillance Network (TSN) - a proprietary antibiotic resistance database with more than 100 million susceptibility results on every available antibiotic - into its report. The MMI study will feature information from TSN such as the rate of key organisms, as well as their resistance to the drugs most frequently included on hospital panels.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.